G Mancia, G De Backer, A Dominiczak, R … - Journal of hypertension, 2007 - journals.lww.com Journal of Hypertension. Wolters Kluwer Health Logo. All Issues. ... Cited by 77 - Related articles - All 8 versions
- ►critcaremed.com M Burnier, A Zanchi - Journal of hypertension, 2006 - journals.lww.com Diabetes (particularly type 2 diabetes) represents a global health problem of
epidemic proportions. Individuals with diabetes are not only more likely to
develop hypertension, dyslipidemia, and obesity, but are also at a ... Cited by 60 - Related articles - BL Direct - All 8 versions
- ►diabetesjournals.org H Ibsen, MH Olsen, K Wachtell, K Borch- … - Diabetes Care, 2006 - Am Diabetes Assoc RESULTS—Increasing baseline albuminuria related to increased risk for
cardiovascular events. Reductions in UACR at years 1 and 2 were ∼33% for
losartan vs. 15% for atenolol (P < 0.001). Benefits of losartan seem to be ... Cited by 52 - Related articles - BL Direct - All 6 versions
- ►onlinejacc.org C Berry, JC Tardif, MG Bourassa - Journal of the American College of Cardiology, 2007 - Elsevier Diabetes mellitus (DM) is a worldwide epidemic. Its prevalence is rapidly
increasing in both developing and developed countries. Coronary heart disease
(CHD) is highly prevalent and is the major cause of morbidity and mortality ... Cited by 44 - Related articles - BL Direct - All 21 versions
J Karalliedde, G Viberti - Journal of human hypertension, 2006 - nature.com The incidence of end-stage renal disease (ESRD) is rising worldwide, accompanied
by corresponding increases in the risk of morbidity and mortality. Underlying
this trend are increasing rates of hypertension and diabetes mellitus, the ... Cited by 44 - Related articles - BL Direct - All 4 versions
DL Jennings, JS Kalus, CI Coleman, C … - Diabetic Medicine, 2007 - pha.nu.ac.th Diabetes mellitus currently affects 18.2 million Americans, roughly 6.3% of the
total population [1]. Diabetic nephropa- thy (DN) affects 10–21% of people
with diabetes mellitus, and is the leading cause of end-stage renal disease ... Cited by 34 - Related articles - View as HTML - BL Direct - All 5 versions
K Jandeleit-Dahm, ME Cooper - Endocrinology and metabolism clinics of North America, 2006 - Elsevier Diabetes and hypertension are comorbid diseases that independently predispose to
renal and cardiovascular complications. Both diseases exacerbate each other in
terms of subsequent renal and cardiovascular complications [1]. Although ... Cited by 19 - Related articles - All 4 versions
S Ogawa, K Takeuchi, T Mori, K Nako, Y … - Hypertension Research, 2007 - nature.com We examined the effects of increasing the recommended initial doses of
angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin receptor
blockers (ARBs), or of switching to combination therapy with both drugs, on ... Cited by 14 - Related articles - BL Direct - All 3 versions
- ►asnjournals.org RE Gilbert, K Connelly, DJ Kelly, CA Pollock, … - Clinical Journal of the American Society of Nephrology, 2006 - Am Soc Nephrol Heart failure (HF) is a major contributor to poor quality of life, a leading
cause of hospitalization, and cause of premature death. Both kidney disease and
diabetes are major and independent risk factors for the development of ... Cited by 15 - Related articles - BL Direct - All 5 versions
MA Weber - The American Journal of Cardiology, 2007 - Elsevier Angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers
(ARBs) differ in their actions on the renin-angiotensin-aldosterone system
(RAAS). ACE inhibitors prevent the formation of angiotensin II, although ... Cited by 13 - Related articles - All 7 versions
